TMED2 as a marker of prognosis in breast cancer [Letter]
Cancer Manag Res
.
2019 Jul 11:11:6377-6378.
doi: 10.2147/CMAR.S210756.
eCollection 2019.
Authors
Megan Catherine Schwarz
1
,
Silvia Allikmets
2
Affiliations
1
Icahn School of Medicine, Mount Sinai Oncological Sciences, New York, NY, USA.
2
Faculty of Life Sciences & Medicine, GKT School of Medical Education, King's College London, London, UK.
PMID:
31372042
PMCID:
PMC6636177
DOI:
10.2147/CMAR.S210756
No abstract available
Publication types
Review